Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A Study of LIPO-5 and ALVAC-HIV (vCP1452) as Possible HIV Vaccines

This study has been completed.
Sponsor:
Collaborator:
French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS)
Information provided by (Responsible Party):
National Institute of Allergy and Infectious Diseases (NIAID)
ClinicalTrials.gov Identifier:
NCT00076063
First received: January 13, 2004
Last updated: March 12, 2015
Last verified: March 2015